Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML
Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML
Not yet recruiting · NCT07604233 · Registry updated 2026-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Not yet recruiting | Phase 1 / Phase 2 | 2026-08-19 | NCT07604233 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| M.D. Anderson Cancer Center | 1145 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UT MD Anderson | Houston | United States | 34 |